{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:49:53Z","timestamp":1775461793462,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00210-025-04799-0","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:43:50Z","timestamp":1763970230000},"page":"6555-6571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced ocular delivery of brinzolamide via \u03b2-cyclodextrin-based micelles for glaucoma management"],"prefix":"10.1007","volume":"399","author":[{"given":"Rashmi","family":"Maurya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Vikal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj Kumar","family":"Narang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balak","family":"Das Kurmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"4799_CR1","doi-asserted-by":"publisher","unstructured":"Akhter MH, Ahmad I, Alshahrani MY, Al-Harbi AI, Khalilullah H, Afzal O, et al (2022) Drug delivery challenges and current progress in nanocarrier-based ocular therapeutic system. 8(2):82. https:\/\/doi.org\/10.3390\/gels8020082","DOI":"10.3390\/gels8020082"},{"key":"4799_CR2","doi-asserted-by":"publisher","unstructured":"Al Yabhouni SA, Mozumder MS, Hassan N, Mourad A-HI, Issa Md TMA (2024) Nanocarrier-based, ocular drug delivery: challenges, prospects, and the therapeutic landscape in the United Arab Emirates.\u00a0Int J Pharm 667:124899. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124899","DOI":"10.1016\/j.ijpharm.2024.124899"},{"key":"4799_CR3","doi-asserted-by":"publisher","unstructured":"Almeida H, Amaral M, Lob\u00e3o P, Lobo J (2013) Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview. Expert opinion on drug delivery. 10(9)1223\u20131237. https:\/\/doi.org\/10.1517\/17425247.2013.796360","DOI":"10.1517\/17425247.2013.796360"},{"key":"4799_CR4","doi-asserted-by":"publisher","unstructured":"Assiri AA, Glover K, Mishra D, Waite D, Vora LK, Thakur RRS (2024) Block copolymer micelles as ocular drug delivery systems. Drug Discovery Today. 29(8):104098. https:\/\/doi.org\/10.1016\/j.drudis.2024.104098","DOI":"10.1016\/j.drudis.2024.104098"},{"key":"4799_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081074","author":"V Aiassa","year":"2023","unstructured":"Aiassa V, Garnero C, Zoppi A, Longhi MR (2023) Cyclodextrins and their derivatives as drug stability modifiers. Pharmaceuticals (Basel, Switzerland). https:\/\/doi.org\/10.3390\/ph16081074","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"4799_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jconrel.2018.03.003","volume":"276","author":"Q Bao","year":"2018","unstructured":"Bao Q, Newman B, Wang Y, Choi S, Burgess DJ (2018) In vitro and ex vivo correlation of drug release from ophthalmic ointments. J Control Release 276:93\u2013101","journal-title":"J Control Release"},{"issue":"6","key":"4799_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/1091581816672187","volume":"35","author":"A Batista-Duharte","year":"2016","unstructured":"Batista-Duharte A, Jorge Murillo G, P\u00e9rez UM, Tur EN, Portuondo DF, Mart\u00ednez BT et al (2016) The hen\u2019s egg test on chorioallantoic membrane: an alternative assay for the assessment of the irritating effect of vaccine adjuvants. Int J Toxicol 35(6):627\u2013633","journal-title":"Int J Toxicol"},{"issue":"5","key":"4799_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1021\/acs.chemrestox.5b00531","volume":"29","author":"B Bhhatarai","year":"2016","unstructured":"Bhhatarai B, Wilson DM, Parks AK, Carney EW, Spencer PJ (2016) Evaluation of TOPKAT, Toxtree, and Derek Nexus in silico models for ocular irritation and development of a knowledge-based framework to improve the prediction of severe irritation. Chem Res Toxicol 29(5):810\u2013822. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00531","journal-title":"Chem Res Toxicol"},{"key":"4799_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejpb.2022.09.008","volume":"180","author":"O Cegielska","year":"2022","unstructured":"Cegielska O, Sierakowski M, Sajkiewicz P, Lorenz K, Kogermann K (2022) Mucoadhesive brinzolamide-loaded nanofibers for alternative glaucoma treatment. Eur J Pharm Biopharm 180:48\u201362","journal-title":"Eur J Pharm Biopharm"},{"key":"4799_CR10","first-page":"117","volume":"4","author":"K Connors","year":"1965","unstructured":"Connors K, Higuchi T (1965) Phase solubility techniques. JAACI 4:117\u2013212","journal-title":"JAACI"},{"key":"4799_CR11","doi-asserted-by":"publisher","unstructured":"de Freitas CF, de Ara\u00fajo Santos J, Pellosi DS, Caetano W, Batistela VR, Muniz EC (2023) Recent advances of Pluronic-based copolymers functionalization in biomedical applications. Biomaterials Advances 151:213484. https:\/\/doi.org\/10.1517\/17425247.2013.796360","DOI":"10.1517\/17425247.2013.796360"},{"key":"4799_CR12","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/S0039-6257(99)00108-3","volume":"44","author":"LJSoo DeSantis","year":"2000","unstructured":"DeSantis LJSoo (2000) Preclinical overview of brinzolamide. Surv Ophthalmol 44:S119\u2013S129","journal-title":"Surv Ophthalmol"},{"key":"4799_CR13","doi-asserted-by":"publisher","unstructured":"Ekici E, Moghimi S (2023) Advances in understanding glaucoma pathogenesis: a multifaceted molecular approach for clinician scientists. Molecular Aspects of Medicine. 94:101223. https:\/\/doi.org\/10.1016\/j.mam.2023.101223","DOI":"10.1016\/j.mam.2023.101223"},{"key":"4799_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27103347","author":"M Farooq","year":"2022","unstructured":"Farooq M, Usman F, Zaib S, Shah HS, Jamil QA, Akbar Sheikh F et al (2022) Fabrication and evaluation of voriconazole loaded transethosomal gel for enhanced antifungal and antileishmanial activity. Molecules. https:\/\/doi.org\/10.3390\/molecules27103347","journal-title":"Molecules"},{"key":"4799_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020389","author":"M Farooq","year":"2023","unstructured":"Farooq M, Usman F, Naseem M, Aati HY, Ahmad H, Manee S et al (2023) Voriconazole cyclodextrin based polymeric nanobeads for enhanced solubility and activity: in vitro\/in vivo and molecular simulation approach. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15020389","journal-title":"Pharmaceutics"},{"issue":"10","key":"4799_CR16","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1021\/acs.molpharmaceut.1c00650","volume":"18","author":"A Gawin-Miko\u0142ajewicz","year":"2021","unstructured":"Gawin-Miko\u0142ajewicz A, Nartowski KP, Dyba AJ, Go\u0142kowska AM, Malec K, Karolewicz B (2021) Ophthalmic nanoemulsions: from composition to technological processes and quality control. Mol Pharm 18(10):3719\u20133740","journal-title":"Mol Pharm"},{"issue":"46","key":"4799_CR17","doi-asserted-by":"publisher","first-page":"27835","DOI":"10.1039\/D0RA04971A","volume":"10","author":"S Gorantla","year":"2020","unstructured":"Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN et al (2020) Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv 10(46):27835\u201327855","journal-title":"RSC Adv"},{"issue":"3","key":"4799_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030761","volume":"9","author":"A Grzybowski","year":"2020","unstructured":"Grzybowski A, Och M, Kanclerz P, Leffler C, De Moraes CGJ (2020) Primary open angle glaucoma and vascular risk factors: a review of population based studies from 1990 to 2019. J Clin Med 9(3):761","journal-title":"J Clin Med"},{"key":"4799_CR19","doi-asserted-by":"publisher","unstructured":"Ghezzi M, Ferraboschi I, Delledonne A, Pescina S, Padula C, Santi P, et al (2022) Cyclosporine-loaded micelles for ocular delivery: investigating the penetration mechanisms. J Control Release. 349:744\u2013755. https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.019","DOI":"10.1016\/j.jconrel.2022.07.019"},{"key":"4799_CR20","doi-asserted-by":"publisher","unstructured":"Grassiri B, Zambito Y, Bernkop-Schn\u00fcrch A (2021) Strategies to prolong the residence time of drug delivery systems on ocular surface. Advances in Colloid and Interface Science. 288:102342. https:\/\/doi.org\/10.1016\/j.cis.2020.102342","DOI":"10.1016\/j.cis.2020.102342"},{"key":"4799_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","volume":"156","author":"D Hwang","year":"2020","unstructured":"Hwang D, Ramsey JD, Kabanov AV (2020) Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval. Adv Drug Deliv Rev 156:80\u2013118","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"4799_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/OPTH.S3182","volume":"2","author":"M Iester","year":"2008","unstructured":"Iester M (2008) Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension. Clinical Ophthalmology (Auckland, NZ) 2(3):517\u2013523","journal-title":"Clinical Ophthalmology (Auckland, NZ)"},{"issue":"2","key":"4799_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejpb.2010.07.005","volume":"76","author":"P Jansook","year":"2010","unstructured":"Jansook P, Stef\u00e1nsson E, Thorsteinsd\u00f3ttir M, Sigurdsson BB, Kristj\u00e1nsd\u00f3ttir SS, Bas JF et al (2010) Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension. Eur J Pharm Biopharm 76(2):208\u2013214","journal-title":"Eur J Pharm Biopharm"},{"key":"4799_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120955","volume":"606","author":"P Jansook","year":"2021","unstructured":"Jansook P, Hnin HM, Loftsson T, Stef\u00e1nsson E (2021) Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - a review. Int J Pharm 606:120955","journal-title":"Int J Pharm"},{"issue":"2","key":"4799_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ceo.14027","volume":"50","author":"KE Keller","year":"2022","unstructured":"Keller KE, Peters DM (2022) Pathogenesis of glaucoma: extracellular matrix dysfunction in the trabecular meshwork-a review. Clin Experiment Ophthalmol 50(2):163\u2013182","journal-title":"Clin Experiment Ophthalmol"},{"key":"4799_CR26","doi-asserted-by":"crossref","unstructured":"Khatoon H, Faudzi SMM, Sohajda T. (2025) Mechanisms and therapeutic applications of \u03b2-cyclodextrin in drug solubilisation and delivery systems. Chemistry & biodiversity. e00359.","DOI":"10.1002\/cbdv.202500359"},{"key":"4799_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082102","author":"NU Khaliq","year":"2023","unstructured":"Khaliq NU, Lee J, Kim S, Sung D, Kim H (2023) Pluronic F-68 and F-127 based nanomedicines for advancing combination cancer therapy. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15082102","journal-title":"Pharmaceutics"},{"key":"4799_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.maturitas.2022.05.002","volume":"163","author":"SS Lee","year":"2022","unstructured":"Lee SS, Mackey DA (2022) Glaucoma - risk factors and current challenges in the diagnosis of a leading cause of visual impairment. Maturitas 163:15\u201322","journal-title":"Maturitas"},{"issue":"1","key":"4799_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1166\/asl.2012.4271","volume":"17","author":"S Li","year":"2012","unstructured":"Li S, Luo X, He J, Xie Y, Li J, Wang N et al (2012) Development of intravenous formulation of a novel multikinase inhibitor for treating cancer based on 2-hydroxypropyl-\u03b2-cyclodextrin inclusion complex. Adv Sci Lett 17(1):320\u2013324","journal-title":"Adv Sci Lett"},{"issue":"3","key":"4799_CR30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1208\/s12249-015-0382-1","volume":"17","author":"H Li","year":"2016","unstructured":"Li H, Liu Y, Zhang Y, Fang D, Xu B, Zhang L et al (2016a) Liposomes as a novel ocular delivery system for brinzolamide: in vitro and in vivo studies. AAPS PharmSciTech 17(3):710\u2013717. https:\/\/doi.org\/10.1208\/s12249-015-0382-1","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"4799_CR31","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1208\/s12249-015-0382-1","volume":"17","author":"H Li","year":"2016","unstructured":"Li H, Liu Y, Zhang Y, Fang D, Xu B, Zhang L et al (2016b) Liposomes as a novel ocular delivery system for brinzolamide: in vitro and in vivo studies. AAPS PharmSciTech 17(3):710\u2013717","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"4799_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/jbm.b.32871","volume":"101","author":"HR Lin","year":"2013","unstructured":"Lin HR, Chang PC (2013) Novel pluronic-chitosan micelle as an ocular delivery system. J Biomed Mater Res B Appl Biomater 101(5):689\u2013699","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"4799_CR33","doi-asserted-by":"publisher","unstructured":"March WF, Ochsner KI (2000) The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension.\u00a0Am J Ophthalmol 129(2):136\u2013143. https:\/\/doi.org\/10.1016\/s0002-9394(99)00343-8","DOI":"10.1016\/s0002-9394(99)00343-8"},{"key":"4799_CR34","doi-asserted-by":"publisher","unstructured":"Maurya R, Vikal A, Patel P, Narang Raj K, Kurmi Balak D (2024) Nanocarrier-based drug delivery of brinzolamide for ocular diseases: a mini-review. Current Nanomedicine 14:1\u201316. https:\/\/doi.org\/10.2174\/0124681873294344240408061056","DOI":"10.2174\/0124681873294344240408061056"},{"key":"4799_CR35","doi-asserted-by":"publisher","unstructured":"Messner M, Kurkov SV, Brewster ME, Jansook P, Loftsson T. (2011) Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone\/cyclodextrin complexes.\u00a0Int J Pharm 407(1):174\u2013183. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.01.011","DOI":"10.1016\/j.ijpharm.2011.01.011"},{"issue":"10","key":"4799_CR36","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/17460441.2021.1922384","volume":"16","author":"F Mincione","year":"2021","unstructured":"Mincione F, Nocentini A, Supuran CT (2021) Advances in the discovery of novel agents for the treatment of glaucoma. Expert Opin Drug Discov 16(10):1209\u20131225","journal-title":"Expert Opin Drug Discov"},{"key":"4799_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11070321","author":"RV Moiseev","year":"2019","unstructured":"Moiseev RV, Morrison PWJ, Steele F, Khutoryanskiy VV (2019) Penetration enhancers in ocular drug delivery. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics11070321","journal-title":"Pharmaceutics"},{"issue":"3","key":"4799_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248857","volume":"16","author":"AB Nair","year":"2021","unstructured":"Nair AB, Shah J, Jacob S, Al-Dhubiab BE, Sreeharsha N, Morsy MA et al (2021) Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections. PLoS One 16(3):e0248857","journal-title":"PLoS One"},{"key":"4799_CR39","doi-asserted-by":"publisher","unstructured":"Naharros-Molinero A, Caballo-Gonz\u00e1lez M, de la Mata FJ, Garc\u00eda-Gallego S. (2022) Direct and reverse Pluronic micelles: design and characterization of promising drug delivery nanosystems. Pharmaceutics. 14(12): 2628. https:\/\/doi.org\/10.3390\/pharmaceutics14122628","DOI":"10.3390\/pharmaceutics14122628"},{"key":"4799_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030976","author":"I Negut","year":"2023","unstructured":"Negut I, Bita B (2023) Polymeric micellar systems-a special emphasis on \u201csmart\u201d drug delivery. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15030976","journal-title":"Pharmaceutics"},{"key":"4799_CR41","doi-asserted-by":"crossref","unstructured":"N\u00fc\u00dfle S, Reinhard T, L\u00fcbke JJD\u00c4I (2021) Acute closed-angle glaucoma\u2014an ophthalmological emergency. 118(45):771","DOI":"10.3238\/arztebl.m2021.0264"},{"issue":"8","key":"4799_CR42","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s13346-022-01182-x","volume":"12","author":"R Pignatello","year":"2022","unstructured":"Pignatello R, Corsaro R, Bonaccorso A, Zingale E, Carbone C, Musumeci T (2022) Soluplus\u00ae polymeric nanomicelles improve solubility of BCS-class II drugs. Drug Deliv Transl Res 12(8):1991\u20132006. https:\/\/doi.org\/10.1007\/s13346-022-01182-x","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"4799_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262\u2013267","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"4799_CR44","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/10717544.2020.1797241","volume":"27","author":"MA Safwat","year":"2020","unstructured":"Safwat MA, Mansour HF, Hussein AK, Abdelwahab S, Soliman GM (2020) Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and in vivo evaluation in a rabbit ocular inflammatory model. Drug Deliv 27(1):1115\u20131124. https:\/\/doi.org\/10.1080\/10717544.2020.1797241","journal-title":"Drug Deliv"},{"key":"4799_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17040447","author":"G Santos","year":"2025","unstructured":"Santos G, Delgado E, Silva B, Braz BS, Gon\u00e7alves L (2025) Topical ocular drug delivery: the impact of permeation enhancers. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics17040447","journal-title":"Pharmaceutics"},{"key":"4799_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23051161","author":"P Saokham","year":"2018","unstructured":"Saokham P, Muankaew C, Jansook P, Loftsson T (2018) Solubility of cyclodextrins and drug\/cyclodextrin complexes. Molecules. https:\/\/doi.org\/10.3390\/molecules23051161","journal-title":"Molecules"},{"issue":"1\u20132","key":"4799_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijpharm.2018.08.001","volume":"549","author":"S Sayed","year":"2018","unstructured":"Sayed S, Elsayed I, Ismail MM (2018) Optimization of \u03b2-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug. Int J Pharm 549(1\u20132):249\u2013260","journal-title":"Int J Pharm"},{"issue":"5","key":"4799_CR48","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.4103\/jfmpc.jfmpc_111_20","volume":"9","author":"SS Senjam","year":"2020","unstructured":"Senjam SS (2020) Glaucoma blindness-a rapidly emerging non-communicable ocular disease in India: addressing the issue with advocacy. J Family Med Prim Care 9(5):2200\u20132206","journal-title":"J Family Med Prim Care"},{"issue":"12","key":"4799_CR49","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.1111\/1750-3841.17527","volume":"89","author":"S Sevim","year":"2024","unstructured":"Sevim S, Sanlier N (2024) Cyclodextrin as a singular oligosaccharide: recent advances of health benefit and in food applications. J Food Sci 89(12):8215\u20138230. https:\/\/doi.org\/10.1111\/1750-3841.17527","journal-title":"J Food Sci"},{"key":"4799_CR50","doi-asserted-by":"publisher","unstructured":"Srivastava V, Patil RK, Mehra NK. (2024) A one-platform comparison study of brinzolamide-loaded liposomes, niosomes, transfersomes, and transniosomes for better management of glaucoma.\u00a0Int J Pharm 666:124741. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124741","DOI":"10.1016\/j.ijpharm.2024.124741"},{"key":"4799_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102137","author":"MA T\u0103nase","year":"2022","unstructured":"T\u0103nase MA, Soare AC, Di\u0163u LM, Nistor CL, Mihaescu CI, Gifu IC et al (2022) Influence of the hydrophobicity of pluronic micelles encapsulating curcumin on the membrane permeability and enhancement of photoinduced antibacterial activity. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14102137","journal-title":"Pharmaceutics"},{"key":"4799_CR52","first-page":"1","volume":"21","author":"P Tekchandani","year":"2020","unstructured":"Tekchandani P, Kurmi BD, Paliwal R, Paliwal SRJAP (2020) Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study 21:1\u201311","journal-title":"Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study"},{"issue":"12","key":"4799_CR53","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1002\/jps.21383","volume":"97","author":"E Vega","year":"2008","unstructured":"Vega E, Gamisans F, Garc\u00eda ML, Chauvet A, Lacoulonche F, Egea MA (2008) PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. J Pharm Sci 97(12):5306\u20135317","journal-title":"J Pharm Sci"},{"key":"4799_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fphar.2018.00091","volume":"09","author":"F Wang","year":"2018","unstructured":"Wang F, Bao X, Fang A, Li H, Zhou Y, Liu Y et al (2018) Nanoliposome-encapsulated brinzolamide-hydropropyl-\u03b2-cyclodextrin inclusion complex: a potential therapeutic ocular drug-delivery system. Front Pharmacol 09:91","journal-title":"Front Pharmacol"},{"key":"4799_CR55","doi-asserted-by":"publisher","unstructured":"Wagner IV, BS, Stewart MW, Dorairaj SK. (2022) Updates on the diagnosis and management of glaucoma. mayo clinic. In: proceedings innovations, Quality & Outcomes. 6(6):618\u2013635. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2022.09.007","DOI":"10.1016\/j.mayocpiqo.2022.09.007"},{"issue":"6","key":"4799_CR56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","volume":"45","author":"KR Wilhelmus","year":"2001","unstructured":"Wilhelmus KR (2001) The Draize eye test. Surv Ophthalmol 45(6):493\u2013515","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"4799_CR57","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1208\/s12249-013-9997-2","volume":"14","author":"W Wu","year":"2013","unstructured":"Wu W, Li J, Wu L, Wang B, Wang Z, Xu Q et al (2013) Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation. AAPS PharmSciTech 14(3):1063\u20131071","journal-title":"AAPS PharmSciTech"},{"key":"4799_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071952","author":"KY Wu","year":"2023","unstructured":"Wu KY, Tan K, Akbar D, Choulakian MY, Tran SD (2023) A new era in ocular therapeutics: advanced drug delivery systems for uveitis and neuro-ophthalmologic conditions. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15071952","journal-title":"Pharmaceutics"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04799-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04799-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04799-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:52:57Z","timestamp":1775458377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04799-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4799"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04799-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Animal Ethics Committee (IAEC) at ISF College of Pharmacy (ISFCP\/IAEC\/CCSEA\/Meeting No. 04\/2024\/Protocol No. 42), Moga, Punjab, ethically approved all animal procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}